Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation NY Valves 2024

Embolic Stroke Unveiled: The Journey of an Interatrial Thrombus in Transit

Presenter: Himaja Dutt Chigurupati

June 05, 2024

Presentation TCT 2023

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

Presenter: Mohammad Akram Kawsara

October 25, 2023

Presentation TCT 2023

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

Presenter: Mouzam Faroqui

October 25, 2023

Presentation TVT 2022

Approach to TAVR in Setting of a Complicated Left Atrial Thrombus in Transit

Presenter: Rimmy Garg

June 08, 2022

Presentation Fellows 2022

My Experience as a Structural Operator

Presenter: Jay Patel

May 07, 2022

Presentation TCT 2020

TRANSIT: Treatment of Failed TAVR With TAVR

Presenter: Luca Testa

October 17, 2020

Presentation TCT 2016

TMVR Clinical Trial Design: Early Insights from Industry

Presenter: Charles J. Davidson, Nicole Ibrahim, Dan Mans

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Presenter: Charles J. Davidson, Nicole Ibrahim, Paul Sorajja

October 30, 2016

Presentation TCT 2016

FDA Perspectives

Presenter: Charles J. Davidson, Nicole Ibrahim, John C Laschinger

October 30, 2016

Presentation TCT 2012

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Presenter: Paul S. Rees, Sean M. Davidson, Sian E. Harding, Perry M. Elliott, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

Advertisement

Embolic Stroke Unveiled: The Journey of an Interatrial Thrombus in Transit

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

Approach to TAVR in Setting of a Complicated Left Atrial Thrombus in Transit

My Experience as a Structural Operator

TRANSIT: Treatment of Failed TAVR With TAVR

TMVR Clinical Trial Design: Early Insights from Industry

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

FDA Perspectives

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content